Microsoft nominates GSK CEO Walmsley to board

GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. Picture taken October 9, 2017. REUTERS/Toby Melville - Copyright Toby Melville(Reuters)

By Reuters

Published on 20/09/2019 - 00:04•Updated 24/04/2024 - 03:44

Comments

(Reuters) - Microsoft Corp said on Thursday it has nominated GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley to its board of directors.

The software company said former chairman of the board of management at BMW AG, Helmut Panke, will not seek a re-election to the board after his current term expires.

Charles Noski, former vice chairman of AT&T Inc and Bank of America Corp, is also leaving the board.

The company's annual shareholder meeting is due on Dec.4.

Shares of the company were up 1.84% in after-market trading after rising to a record high during the regular trading hours after it announced a $40 billion (31.90 billion pounds) share buyback plan.

(Reporting by Neha Malara in Bengaluru; Editing by Arun Koyyur)

Comments

The Playstation VR2 is on display during a Sony news conference before the start of the CES tech show Wednesday, Jan. 4, 2023, in Las Vegas.

Now playing Next

Business

Microsoft nominates GSK CEO Walmsley to board

You might also like

Sony to cut about 900 PlayStation jobs as gaming layoffs continue